5-Amino-1MQ 50mg
$65.005-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule NNMT inhibitor studied in cellular NAD+ pathway research, supplied as a lyophilized powder.
Showing all 6 results
-
-
GLP-2/T 10mg
$60.00GLP-2/T is a dual GIP and GLP-1 receptor agonist developed to improve glucose tolerance and adiposity management. It mimics the body’s natural incretin signaling to enhance insulin sensitivity, suppress appetite, and reduce body-fat mass.
Buy 2–3 save 5% · 4–5 save 10% · 6+ save 15%
-
GLP-2/T 30mg
$115.00GLP-2/T is a dual GIP and GLP-1 receptor agonist developed to improve glucose tolerance and adiposity management. It mimics the body’s natural incretin signaling to enhance insulin sensitivity, suppress appetite, and reduce body-fat mass.
Buy 2–3 save 5% · 4–5 save 10% · 6+ save 15%
-
GLP-3/R 10mg
$70.00GLP-3/R is a next-generation metabolic peptide designed as a triple-agonist for the GLP-1, GIP, and glucagon receptors. Early human trials suggest profound effects on glucose regulation, appetite control, and body-weight reduction.
By targeting three key hormonal pathways simultaneously, GLP-3R represents an evolution beyond single-agonist incretin therapies.
Buy 2–3 save 5% · 4–5 save 10% · 6+ save 15%
-
GLP-3/R 20mg
$100.00GLP-3/R is a next-generation metabolic peptide designed as a triple-agonist for the GLP-1, GIP, and glucagon receptors. Early human trials suggest profound effects on glucose regulation, appetite control, and body-weight reduction.
By targeting three key hormonal pathways simultaneously, GLP-3R represents an evolution beyond single-agonist incretin therapies.
Buy 2–3 save 5% · 4–5 save 10% · 6+ save 15%
-
GLP-3/R 50mg
$175.00GLP-3/R is a next-generation metabolic peptide designed as a triple-agonist for the GLP-1, GIP, and glucagon receptors. Each vial contains 50mg — our highest concentration option for extended research protocols.
Buy 2–3 save 5% · 4–5 save 10% · 6+ save 15%